Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Cash

<< Previous

Bullboard Posts

Next >>

Comment by alleyesonmeon Mar 10, 2022 5:58pm

124 Views

Post# 34504751

RE:RE:RE:RE:Cash

New CEO is involved in Q4 because he took control on Nov 15th....anyone's guess on results....things can't get much worse...improvement in revenues and loss may be much higher than most anticipated...in my experience company's about to report bad earnings are opposite of quite....I think longs may be in for a very pleasant surprise...CFO only awarded option to purchase up to 1m shares at .18c....I also believe financial struggles from LP's will have them returning to white label extract service and this amongst other things will be part of the comeback story of 2022

<< Previous

Bullboard Posts

Next >>

@ the Bell: TSX advances to start off Christmas trading week